[DNA Repair Function and Mutation of an H2B Monoubiquitination Factor WDR70 in Ovarian Cancer]

Area of Science:

• Molecular biology
• Genetics
• Oncology

Background:

• The Cullin4 (CRL4) ubiquitin ligase complex is involved in various cellular processes.
• Understanding the specific roles of CRL4 family members like WDR70 in DNA repair is crucial.
• Ovarian cancer is a significant health concern with complex genetic underpinnings.

Purpose of the Study:

• To investigate the function of CRL4 complex members, specifically DDB1 and WDR70, in DNA repair pathways.
• To identify mutations in WDR70 and their correlation with ovarian cancer development.
• To explore the potential of CRL4 as a therapeutic target for ovarian cancer.

Main Methods:

• Immunofluorescence assays to detect DNA repair markers (γH2AX, RPA32) after DDB1 or WDR70 knockdown.
• 5-bromo-2'-deoxyuridine (BrdU) immunohistochemistry to assess DNA replication.
• Semiquantitative PCR and DNA sequencing to analyze CRL4 gene expression and mutations in ovarian cancer tissues.

Main Results:

• CRL4 subunits exhibit distinct roles in DNA damage checkpoint activation and homologous recombination (HR).
• DDB1 is involved in both checkpoint activation and HR, while WDR70 is specifically required for DNA end resection and RPA32 loading in HR.
• WDR70 dosage does not affect DNA replication; however, WDR70 transcripts are diminished or truncated in 50% of ovarian cancers, often due to mutations.

Conclusions:

• The CRL4 ubiquitin ligase complex is essential for multiple DNA repair pathways and maintaining genome stability.
• WDR70 mutations and altered expression in ovarian cancer highlight its role in tumorigenesis.
• CRL4 complex, particularly WDR70, represents a potential therapeutic target and anticancer barrier against ovarian malignancies.